Showing results (121-130 of 130) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Neuron|March 25, 2014
Dorsal raphe neurons signal reward through 5-HT and glutamateZhixiang Liu, Jingfeng Zhou, Yi Li, et al.Human Molecular Genetics|December 26, 2013
Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscleAndrea Henriques-Pons, Qing Yu, Sree Rayavarapu, et al.BMC Genomics|November 25, 2015
RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and allelesAmy Webb, Audrey C Papp, Amanda Curtis, et al.Nature Communications|August 26, 2025
Dynamic construction of a durable epitaxial catalytic layer for industrial alkaline water splittingBin Chang, Xiaoyan Liu, Shouwei Zuo, et al.Cell Metabolism|May 26, 2021
Neurotensin is an anti-thermogenic peptide produced by lymphatic endothelial cellsJin Li, Erwei Li, Rafael S Czepielewski, et al.The Journal of Infection|July 6, 2015
Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: Virological and clinical findingsMing Pan, Rongbao Gao, Qiang Lv, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 6, 2022
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b StudyYuankai Shi, Baolan Li, Lin Wu, et al.Nature Medicine|July 11, 2024
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trialYing Cheng, Jianhua Chen, Wei Zhang, et al.Maturitas|December 25, 2025
Practice guideline for the treatment and management of iatrogenic premature ovarian insufficiencyXiangyan Ruan, Che Xu, Hefeng Huang, et al.Nature Medicine|January 22, 2025
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Yanqiao Zhang, Ziyu Li, et al.Pageof 13